Navigation Links
Escape Nitinol Stone Retrieval Device

ProductsEscape Nitinol Stone Retrieval Device
Company Boston Scientific Corporation
Item Escape Nitinol Stone Retrieval Device
Features 
  • 1.9Fr Sheath provides optimal irrigation flow over 2.2F and 2.4F devices. When passed through a 3.6F scope working channel, the 1.9F sheath and 200 laser fiber provide irrigation flow equivalent to a 2.4F device.
  • Nitinol Tipless basket design is constructed of a nitinol tube which has been laser cut to remove excess nitinol material leaving the 4-wire basket cage.
Description The Escape Basket offers a side-by-side approach, unique to the market, for using a nitinol basket and holmium laser fiber together-providing physician control and independent manipulation of both the basket and laser fiber.
Info Boston Scientific Corporation
Customer Service: (888) 272-1001
Web site: http://www.bostonscientific.com

Related medicine products :

1. ResMed S8 Escape
2. Sentinol™ Self-Expanding Nitinol Biliary Stent System
3. Strange Cholangiography Set: With N-Circle® Nitinol Tipless Stone Extractor
4. Common Duct Exploration Set: With N-Circle® Nitinol Tipless Stone Extractor
5. N-Circle® Nitinol Tipless Stone Extractor
6. NForce Nitinol Helical Stone Extractors
7. NCircle Nitinol Tipless Stone Extractors
8. Ncircle® Nitinol Tipless Stone Extractor with Unidex Handle
9. Ncircle® Nitinol Tipless Stone Extractor - Helical Basket with Unidex Handle
10. Ncircle® Nitinol Tipless Stone Extractors - RHR Replacement Stone Extractors
11. Ncircle® Nitinol Tipless Stone Extractors with Delta Wire®
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
Medicine Products:
(Date:12/3/2008)...ific Gamma Imaging (BSGI) has,equivalent sensitiv...ents with,inconclusive findings after mammography..., according to findings presented today at the ann...America (RSNA). BSGI is a molecular breast,imagin...phy that can identify,lesions independent of tiss...
(Date:12/3/2008)...irstCall/ -- MAP,Pharmaceuticals, Inc. (Nasdaq: ...rticipate in a panel discussion titled "Adapting S... the 2008 RBC Capital Markets Healthcare Conferenc...T) in New York City. , A live webcast of th...or,Relations section of MAP Pharmaceuticals, webs...
(Date:12/3/2008)...thinner imported from China , , WEDNESDA...e deadly contamination of the blood thinner hepari...de chemical that was added to batches of the drug ..., The crisis, which began last November, resulted... in the United States. The Chinese heparin, contam...
(Date:12/3/2008)...The gold coin tradition continues for The Salvatio...d into the red kettles, with the first coin appear...$50 coin was wrapped in a $2 bill and deposited in... in Norridge. , , Since the first gold coin...ation Army has seen gold coins of every type and d...
Breaking Medicine News(10 mins):Health News:Molecular Breast Imaging Outperforms MRI for Patients With Inconclusive Results in the Diagnosis of Cancer 2Health News:Report Confirms Source of Contaminated Heparin 2Health News:Report Confirms Source of Contaminated Heparin 3
...ding to a new study from Columbia University rese...vement disorder, essential tremor (ET),// are more...healthy counterparts. Essential tremor is a disord...ieve it may be neurodegenerative in nature. The co...
...ding to a new study in the American Journal of Cli... play an important role in preventing the build up...vascular disease.// Research has shown antioxidant...ation of plaque in the arteries. However, most stu...
...ding to a notice distributed by the agency, the US...nited Therapeutics Corp.'s pulmonary arterial hype...A spokesperson for the FDA told Reuters Health tha... pulmonary arterial hypertension. The FDA approved...
...tists have ruled out a possible connection to auti...l Journal shows children with autism are no more l...stinal problems as infants. // Study investigators...children with autism and compared them to children...
Other Medicine News:
(Date:12/3/2008)...viates long-term anemia and organ damage in mice a... MEMPHIS, Tenn., Dec. 3 /PRNewswire-USNewswire/ -...ne into mouse blood cells, scientists at St. Jude ...e cell disease pathology. In their studies, the re...tially no difference from normal mice. Although th...
(Date:12/3/2008)... Bionovo, Inc.,(Nasdaq: ... the company,s,manufacturing and control process ...how Bionovo can move forward with the development ...hot flashes. , "We have concluded three CMC...ess the Agency,s recommendations for further devel...
(Date:12/2/2008)...swire/ -- IBT Laboratories, a leading clinical-di...alizing in immunology and allergy assays, announce... response of patients whose immune systems may be ...rder, chemotherapy drugs, or because they are taki...f a transplant. The company launched the two new a...
(Date:12/1/2008)...Dec. 2 A study has foun...technique for imaging the breast, is not affected ...tus, two factors that limit the effectiveness of s...esults will be presented today at the annual meeti...SNA). , , "The ability of PEM to detect ca...
Breaking Medicine Technology:Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 2Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 3Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings 4IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic 354 1Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic 354 2FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125 1775 1FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125 1775 2FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125 1775 3Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 1770 1Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 1770 2Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 1770 3Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia 1770 4bioMETRX Inc Acquires Patent for Biometric Padlock 520 1bioMETRX Inc Acquires Patent for Biometric Padlock 520 2
...S--(BUSINESS WIRE)--July 8, 2007 - Cougar Biotechn...tive Phase I and Phase,II data on the Company,s pr...cetate) were presented at the European Society for...ently taking place,in Lugano, Switzerland. The dat...ons on Sunday, July 8, as part of the session for,...
...GA, ON, July 09, 2007 /PRNewswire-FirstCall/ - YM,...fies, develops,and commercializes differentiated p...at a study presented by investigators from Kinki,U...at the 11th,meeting of The Japanese Association fo...5-6, 2007 demonstrated the increased,radiosensitiv...
Other Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 4Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 5Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference 6YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 2YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 3YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 4